Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease

Daniel W. Curry, Bernardo Stutz, Zane Bruce Andrews, John D. Elsworth
ISSN / E-ISSN
— / —
DOI
10.3233/jpd-171296 ↗
Volume · Issue · Pages
8 · 2 · 161-181
Publisher
IOS Press BV
Article URL
https://doi.org/10.3233/jpd-171296 ↗
Article details
Unverified
Publication date (each date has its type and source)
27 Mar 2018
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date27 Mar 2018 OpenAlex

Keywords (as given): Parkinson's disease; AMPK signaling; neuroprotection; metformin; alpha-synuclein aggregates; dopaminergic neuron loss; energy homeostasis; neurodegeneration; AMPK agonists

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
Journal of Parkinson's Disease
Publication date used
27 Mar 2018 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.